No Data
No Data
Special treat (ST) Texin (000070.SZ): the company and Teli do not involve in the same industry competition.
On July 19th, Gelunhui reported that special treat special trust (000070.SZ) stated on the investor interaction platform that, as far as they know, the company and Teli are not involved in the same industry competition.
Shenzhen SDG Information: 2024 Interim Performance Forecast
ST Special Treat (000070.SZ): Expected to lose between 21 million and 30 million yuan in the first half of the year.
ST Special Treat (000070.SZ) announced its performance forecast for the first half of 2024. According to preliminary calculations by the finance department, it is expected that the net income attributable to the shareholders of the listed company will be a loss of RMB 2.1 million-3 million in the first half of 2024, compared to a loss of RMB 15.2213 million in the same period last year. After deducting non-recurring gains and losses, the net income loss will be RMB 42 million-60 million, compared to a loss of RMB 54.1926 million in the same period last year. The basic earnings per share is expected to be a loss of RMB 0.0033-0.0023 per share. The net profit attributable to shareholders of the listed company during the reporting period will be a year-on-year decrease.
Special treat Techcombank (000070.SZ): the company provides optical cable and access products to Huawei.
On July 12th, Gelonhui reported that Special Treat TeXin (000070.SZ) stated on the investor interaction platform that the company provided optical cables and access products to Huawei.
As of June 28, the number of people holding shares of Special Treat Communications (000070.SZ) was 71,191.
ST Techcom (000070.SZ) stated on the investor communication platform on July 12th that the number of shareholders holding company's shares as of June 28th, 2024 was 71,191.
Special treat TechFaith (000070.SZ): The chip project is still in the stage of development and is planned to be used in supporting products.
On June 20th, Gelonhui: An investor asked ST Special Treat (000070.SZ) on the investor communication platform, 'Where is your self-developed chip currently used?' The company responded that the company's chip project is still in the stage of phased research and development and is planned to be used in supporting products. The research and development project's research results and market promotion both have uncertainty, and investors should pay attention to the risks. The company has not received any information about major shareholders injecting assets or mergers and acquisitions and reorganizations. The company will strictly comply with the requirements of regulatory authorities to fulfill disclosure obligations.
No Data